theMednetRegister
  • Community
    • Overview
    • Experts
    • Editors
    • Fellows
    • Code of conduct
    • AI Guidelines for Physicians
  • Company
    • About Us
    • FAQs
    • Privacy Policy
    • Terms of Use
    • Careers
    • Programs
  • News
    • News Releases
    • Press Coverage
    • Publications
    • Blog
  • Contact Us
  • Sign in

Primary Care

Neuro-Ophthalmology   

Questions discussed in this category


How often and in what way do you monitor patients who are receiving teprotumumab (Tepezza) for thyroid eye disease?
1 Answer available

How do you make the decision to empirically treat for GCA when a patient is referred but cannot be immediately seen in clinic?
When a PCP calls with concern for GCA and is wondering whether to start empiric steroids what data do you prioritize to make that decision and do you ...
4 Answers available

Do you generally recommend low dose aspirin for patients with giant cell arteritis?
2 Answers available

Would you recommend medical therapy for asymptomatic idiopathic intracranial hypertension with completely normal visual field testing?
2 Answers available

How long do you continue steroid-sparing agents such as tocilizumab for GCA once the disease is in remission off steroids?
1 Answer available
197041889512443124218388


Papers discussed in this category


Ann Intern Med, 2020 Sep 22
Risk for Serious Infection With Low-Dose Glucocorticoids in Patients With Rheumatoid Arthritis : A Cohort Study.

Arthritis Rheum,
Low-dose aspirin and prevention of cranial ischemic complications in giant cell arteritis.

BMC musculoskeletal disorders, 2016-08-24
The effect of clinical features and glucocorticoids on biopsy findings in giant cell arteritis.

Related Topics in Primary Care

  • Lung Cancer
  • Workload
  • Breast Cancer
  • Head and Neck Cancers
  • Hematologic Malignancies
  • Radiation Oncology
  • Gynecologic Oncology
  • Palliation
  • Neuro-Oncology
  • Gastrointestinal Cancers

Copyright © 2025 theMednet
All Rights Reserved.